United States · FDA National Drug Code directory

DAYVIGO

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
62856-410_c82838dc-6934-4541-8a02-bd44ee5bb82a
Product NDC
62856-410
Form
TABLET, FILM COATED
Composition / generic term
lemborexant
Labeler
Eisai Inc.
Marketing category
NDA
Marketing start / end (source format)
20200407
Source listing expiry
20261231

Source-listed ingredients

  • LEMBOREXANT — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (62856-410-30) · 62856-410-30
  • 90 TABLET, FILM COATED in 1 BOTTLE (62856-410-90) · 62856-410-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →